Cervical human papillomavirus among 19 753 women attending gynecological department of a major comprehensive hospital in north Anhui China 2013‐2016: Implication for cervical cancer screening and prevention

Author:

Liu Hongli1,Wei Xueting2,Xie Zongyu3,Wang Xiaojing2,Gong Xiaomeng4,Ke Wujian56,Zou Huachun78ORCID

Affiliation:

1. Department of Gynecological OncologyFirst Affiliated Hospital of Bengbu Medical CollegeBengbu Anhui China

2. Anhui Clinical and Preclinical Key Laboratory of Respiratory Diseases, Department of RespirationFirst Affiliated Hospital of Bengbu Medical CollegeBengbu Anhui China

3. Department of RadiologyFirst Affiliated Hospital of Bengbu Medical CollegeBengbu Anhui China

4. Department of PathologyFirst Affiliated Hospital of Bengbu Medical CollegeBengbu Anhui China

5. Dermatologist Clinical Research CenterDermatology Hospital, Southern Medical UniversityGuangzhou China

6. Guangdong Provincial Center for STI & Skin Diseases Control and Prevention, Guangdong Provincial Dermatology HospitalGuangzhou China

7. School of Public Health (Shenzhen), Sun Yat‐sen UniversityShenzhen China

8. Kirby Institute, University of New South Wales NSW Australia

Funder

National Health and Medical Research Council

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference31 articles.

1. Epidemiologic classification of human papillomavirus types associated with cervical cancer;Muñoz N;N Engl J Med,2003

2. SaraiyaMPopulation‐based HPV genotype attribution in HPV‐associated cancers. Presented at Anal Intraepithelial Neoplasia Society Conference March 13‐15 2015 Atlanta GA.

3. US Food and Drug Administration. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV.www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm426485.htm. Accessed 14 June 2018.

4. Global burden of human papillomavirus and related diseases;Forman D;Vaccine,2012

5. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia;Palefsky JM;N Engl J Med,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3